Boothbay Fund Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$597K Buy
339,402
+318,213
+1,502% +$690K 0.01% 1247
2025
Q4
$49.8K Sell
21,189
-41,961
-66% -$115K ﹤0.01% 1821
2025
Q3
$193K Buy
+63,150
New +$180K ﹤0.01% 1652
2021
Q2
Sell
-10,420
Closed -$79K 1885
2021
Q1
$79K Buy
+10,420
New +$118K ﹤0.01% 1483
2020
Q4
Sell
-43,770
Closed -$545K 1252
2020
Q3
$545K Buy
+43,770
New +$484K 0.03% 619

Other funds holding CLOV

Boothbay Fund Management's CLOV Position: Q1 2026 in Review

Boothbay Fund Management increased its Clover Health Investments (CLOV) stake by 1,502% in Q1 2026, buying an estimated $690K and bringing the position to 339,402 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #1247.

Boothbay Fund Management first reported a position in CLOV in Q3 2020 and has held it in 5 quarters since. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • Boothbay Fund Management held 339,402 shares of Clover Health Investments worth $597K as of Q1 2026.
  • Boothbay Fund Management bought 318,213 Clover Health Investments shares in Q1 2026, an estimated $690K.
  • Clover Health Investments made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1247 holding.
  • Boothbay Fund Management first reported a position in Clover Health Investments in Q3 2020 and has held it in 5 quarters since.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.